Search Results - "Yanda, K."

Refine Results
  1. 1

    Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease by Cebotaru, Liudmila, Liu, Qiangni, Yanda, Murali K, Boinot, Clement, Outeda, Patricia, Huso, David L, Watnick, Terry, Guggino, William B, Cebotaru, Valeriu

    Published in Kidney international (01-07-2016)
    “…Abnormal proliferation of cyst-lining epithelium and increased intracystic fluid secretion via the cystic fibrosis transmembrane conductance regulator (CFTR)…”
    Get more information
    Journal Article
  2. 2

    VX‐809 mitigates disease in a mouse model of autosomal dominant polycystic kidney disease bearing the R3277C human mutation by Yanda, Murali K., Cebotaru, Liudmila

    Published in The FASEB journal (01-11-2021)
    “…Autosomal dominant polycystic kidney disease (ADPKD) is associated with the formation of renal cysts. We have devised a therapeutic approach, based on…”
    Get full text
    Journal Article
  3. 3

    Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse model by Yanda, Murali K, Zeidan, Adi, Cebotaru, Liudmila

    “…Systemic and portal hypertension, liver fibrosis, and hepatomegaly are manifestations associated with autosomal recessive polycystic kidney disease (ARPKD),…”
    Get more information
    Journal Article
  4. 4

    A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector by Yanda, Murali K., Liu, Qiangni, Cebotaru, Liudmila

    Published in The Journal of biological chemistry (20-07-2018)
    “…Autosomal dominant polycystic kidney disease (ADPKD) is associated with progressive enlargement of cysts, leading to a decline in function and renal failure…”
    Get full text
    Journal Article
  5. 5

    An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease by Yanda, Murali K, Liu, Qiangni, Cebotaru, Liudmila

    “…Adult-onset autosomal-dominant polycystic kidney disease (ADPKD) is caused by mutations in either the or gene, leading to malfunction of their gene products,…”
    Get more information
    Journal Article
  6. 6

    CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease by Yanda, Murali K, Ciobanu, Cristian, Guggino, William B, Cebotaru, Liudmila

    “…Defects in the primary cilium are associated with autosomal dominant polycystic kidney disease (ADPKD). We used a combination of animal models, Western…”
    Get more information
    Journal Article
  7. 7

    Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease by Yanda, Murali K., Cha, Boyoung, Cebotaru, Cristina V., Cebotaru, Liudmila

    Published in The Journal of biological chemistry (08-11-2019)
    “…Autosomal-dominant polycystic kidney disease (ADPKD) induces a secretory phenotype, resulting in multiple fluid-filled cysts. We have previously demonstrated…”
    Get full text
    Journal Article
  8. 8

    Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease by Yanda, Murali K., Liu, Qiangni, Cebotaru, Valeriu, Guggino, William B., Cebotaru, Liudmila

    Published in The Journal of biological chemistry (27-10-2017)
    “…Autosomal dominant polycystic kidney disease (ADPKD) is associated with progressive enlargement of multiple renal cysts, often leading to renal failure that…”
    Get full text
    Journal Article
  9. 9

    Short-Term Steroid Treatment of Rhesus Macaque Increases Transduction by Yanda, Murali K, Tomar, Vartika, Cebotaru, Cristina Valeria, Guggino, William B, Cebotaru, Liudmila

    Published in Human gene therapy (01-02-2022)
    “…Repeat dosing poses a major hurdle for the development of an adeno-associated virus (AAV)-based gene therapy for cystic fibrosis, in part because of the…”
    Get more information
    Journal Article
  10. 10

    A new role for heat shock factor 27 in the pathophysiology of Clostridium difficile toxin B by Yanda, Murali K, Guggino, William B, Cebotaru, Liudmila

    “…(CD) is a common pathogen that causes severe gastrointestinal inflammatory diarrhea in patients undergoing antibiotic therapy. Its virulence derives from two…”
    Get more information
    Journal Article
  11. 11

    The Mitochondrial Ca2+ import complex is altered in ADPKD by Yanda, Murali K, Tomar, Vartika, Cole, Robert, Guggino, William B., Cebotaru, Liudmila

    Published in Cell calcium (Edinburgh) (01-01-2022)
    “…•ADPKD is associated with altered mitochondrial calcium uptake which fuels cyst growth.•87 characters. Mutations in either of the polycystic kidney disease…”
    Get full text
    Journal Article
  12. 12

    Role of calcium in adult onset polycystic kidney disease by Yanda, Murali K., Liu, Qiangni, Cebotaru, Valeriu, Guggino, William B., Cebotaru, Liudmila

    Published in Cellular signalling (01-01-2019)
    “…Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in genes encoding the polycystin (PC) 1 and 2 proteins. The goal of this study was…”
    Get full text
    Journal Article
  13. 13

    Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease by Yanda, Murali K., Tomar, Vartika, Cebotaru, Liudmila

    “…Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in PKHD1, encoding fibrocystin/polyductin (FPC). Severe disease occurs in…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Rescue of CFTR NBD2 mutants N1303K and S1235R is influenced by the functioning of the autophagosome by Liu, Qiangni, Sabirzhanova, Inna, Yanda, Murali K., Bergbower, Emily A.S., Boinot, Clément, Guggino, William B., Cebotaru, Liudmila

    Published in Journal of cystic fibrosis (01-09-2018)
    “…The missing phenylalanine at position 508, located in nucleotide-binding domain (NBD1) of the cystic fibrosis transmembrane regulator (CFTR), is the most…”
    Get full text
    Journal Article
  16. 16

    Reproductive health and human rights by Yanda, K., Smith, S.V., Rosenfield, A.

    “…Reproductive health programs should adopt an approach based on human rights at the levels of clinical management as well as national policy, especially those…”
    Get full text
    Journal Article
  17. 17

    Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney DiseaseSummary by Murali K. Yanda, Vartika Tomar, Liudmila Cebotaru

    “…Background & Aims: Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in PKHD1, encoding fibrocystin/polyductin (FPC). Severe disease…”
    Get full text
    Journal Article
  18. 18

    Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors by Wang, Li-Hua, Wang, Ning, Lu, Xiao-Yu, Liu, Bing-Chen, Yanda, Murali K., Song, John Z., Dai, Helena M., Sun, Yu-Liang, Bao, Hui-Fang, Eaton, Douglas C., Ma, He-Ping

    Published in Biochimica et biophysica acta (01-02-2012)
    “…Kv1.3 channels play an important role in modulating lymphocyte proliferation and apoptosis. We hypothesized that Kv1.3 channels in B lymphocytes might be…”
    Get full text
    Journal Article
  19. 19
  20. 20